Drugs

Title

Date Published

The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model.

February 1, 2006

Use of Recombinant Activated Factor VII (Novoseven) in Trauma and Surgery: Analysis of Outcomes Reported to an International Registry.

January 31, 2006

Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.

January 30, 2006

Effect of topical tranexamic acid in open heart surgery.

January 27, 2006

Ultra-early Hemostatic Therapy for Acute Intracerebral Hemorrhage.

January 1, 2006

Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.

January 1, 2006

Does aprotinin reduce blood loss in total hip arthroplasty?

January 1, 2006

The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage.

January 1, 2006

Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.

January 1, 2006

A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting.

January 1, 2006

A double-blind, placebo-controlled trial of epsilon-aminocaproic Acid for reducing blood loss in coronary artery bypass grafting surgery.

December 19, 2005

Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss.

December 1, 2005

Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials.

December 1, 2005

Hemostatic Effects of Phospholipid Vesicles Carrying Fibrinogen gamma Chain Dodecapeptide in Vitro and in Vivo.

November 16, 2005

Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

October 7, 2005

Control of Bleeding Caused by Thrombocytopenia Associated With Hematologic Malignancy: An Audit of the Clinical Use of Recombinant Activated Factor VII.

October 1, 2005

Activated recombinant factor VII in cardiac surgery.

February 1, 2005

Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.

October 1, 2004

The effect of recombinant factor VIIa (NovoSeven(R)) on peri-operative bleeding during total knee replacement in a non-hemophiliac patient.

August 30, 2004

Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia.

June 1, 2004